JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB146181

AH-7614, FFA4/GPR120 antagonist

Be the first to review this product! 리뷰 제출

|

(1 출판물)

MW 351.4 Da. Selective FFA4/GPR120 antagonist. Inhibits linoleic acid (ab141144)-induced intracellular calcium accumulation.

대체 명칭 보기

BMIQ10, Free fatty acid receptor 4, G-protein coupled receptor 120, G-protein coupled receptor 129, G-protein coupled receptor GT01, G-protein coupled receptor PGR4, GPR 120, GPR 129, GT01, HGNC:19345, MGC119984, O3FA1_HUMAN, O3FAR1, Omega-3 fatty acid receptor 1, PGR 4

1 이미지
Chemical Structure - AH-7614, FFA4/GPR120 antagonist (AB146181)
  • Chemical Structure

Lab

Chemical Structure - AH-7614, FFA4/GPR120 antagonist (AB146181)

2D chemical structure image of ab146181, AH-7614, FFA4/GPR120 antagonist

주요 정보

CAS 번호

6326-06-3

Molecular weight

351.4 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>1</sub><sub>7</sub>NO<sub>3</sub>S

PubChem

233085

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

생화학적 명칭

4-Methyl-N-(9H-xanthen-9-yl)benzenesulfonamide

생물학적 정보

Selective FFA4/GPR120 antagonist. Inhibits linoleic acid (ab141144)-induced intracellular calcium accumulation.

Canonical SMILES

CC1=CC=C(C=C1)S(=O)(=O)NC2C3=CC=CC=C3OC4=CC=CC=C24

InChi

InChI=1S/C20H17NO3S/c1-14-10-12-15(13-11-14)25(22,23)21-20-16-6-2-4-8-18(16)24-19-9-5-3-7-17(19)20/h2-13,20-21H,1H3

InChiKey

OZCQEUZTOAAWDK-UHFFFAOYSA-N

IUPAC Name

4-methyl-N-(9H-xanthen-9-yl)benzenesulfonamide

특성 및 보관 정보

배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
Ambient
적절한 장기 보관 조건
Ambient
보관 정보
The product can be stored for up to 12 months
취급 방법

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The G-protein coupled receptor GPR120 also known as free fatty acid receptor 4 (FFA4) is a receptor with a molecular mass of approximately 42 kDa. It is expressed widely in human adipose tissue intestine and pancreas. This receptor acts as a sensor for long-chain fatty acids especially omega-3. It is integral in responding to dietary fats and influences several downstream signaling mechanisms.
Biological function summary

The GPR120 receptor plays a significant role in metabolic regulation and inflammation control. It is not part of a larger protein complex but functions as a solo receptor. Its activation can lead to anti-inflammatory effects and improved insulin sensitivity contributing to the homeostasis of glucose and lipid metabolism. GPR120 engagement by its ligands initiates a cascade of cellular responses emphasizing its importance in metabolic pathways.

Pathways

Four major ways exist through which GPR120 operates to influence metabolic health. It is involved in the insulin-sensitizing pathway and the anti-inflammatory pathway. When activated GPR120 couples with Gαq/11 proteins to initiate intracellular signaling influencing downstream proteins such as Akt and ERK1/2. This linkage is important for its role in reducing inflammation and improving insulin sensitivity aligning with other receptors like GPR40 which similarly respond to fatty acids.

GPR120 has implications in type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Dysregulation of GPR120 signaling is associated with reduced insulin response highlighting its connection to diabetes. Similarly in NAFLD improper function or expression of GPR120 leads to fat accumulation in liver cells. It is linked to inflammatory proteins like TNF-alpha where altered GPR120 activity modulates TNF-alpha levels influencing inflammation and metabolic imbalance.

제품 프로토콜

제품이 사용된 논문 (1)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Frontiers in pharmacology 14:1197743 PubMed37583904

2023

Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia.

Applications

Unspecified application

Species

Unspecified reactive species

Yuta Yamamoto,Katsuya Narumi,Naoko Yamagishi,Toshio Nishi,Takao Ito,Ken Iseki,Masaki Kobayashi,Yoshimitsu Kanai
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com